Literature DB >> 33739187

Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder.

Carlos A Zarate1.   

Abstract

Entities:  

Keywords:  clinical practice guidelines; ketamine; major depressive disorder

Year:  2021        PMID： 33739187      PMCID： PMC8138742          DOI： 10.1177/07067437211004023

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  6 in total

1.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Authors:  Carlos A Zarate; Jaskaran B Singh; Paul J Carlson; Nancy E Brutsche; Rezvan Ameli; David A Luckenbaugh; Dennis S Charney; Husseini K Manji
Journal:  Arch Gen Psychiatry       Date:  2006-08

2.  The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur.

Authors:  Jennifer Swainson; Alexander McGirr; Pierre Blier; Elisa Brietzke; Stéphane Richard-Devantoy; Nisha Ravindran; Jean Blier; Serge Beaulieu; Benicio N Frey; Sidney H Kennedy; Roger S McIntyre; Roumen V Milev; Sagar V Parikh; Ayal Schaffer; Valerie H Taylor; Valérie Tourjman; Michael van Ameringen; Lakshmi N Yatham; Arun V Ravindran; Raymond W Lam
Journal:  Can J Psychiatry       Date:  2020-11-11       Impact factor: 4.356

Review 3.  Neurobiological biomarkers of response to ketamine.

Authors:  Bashkim Kadriu; Elizabeth D Ballard; Ioline D Henter; Stephen Murata; Nimesha Gerlus; Carlos A Zarate
Journal:  Adv Pharmacol       Date:  2020-06-18

Review 4.  The role of dissociation in ketamine's antidepressant effects.

Authors:  Elizabeth D Ballard; Carlos A Zarate
Journal:  Nat Commun       Date:  2020-12-22       Impact factor: 14.919

5.  A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.

Authors:  Jennifer L Phillips; Natalia Jaworska; Elizabeth Kamler; Venkat Bhat; Jean Blier; Jane A Foster; Stefanie Hassel; Keith Ho; Lisa McMurray; Roumen Milev; Zahra Moazamigoudarzi; Franca M Placenza; Stéphane Richard-Devantoy; Susan Rotzinger; Gustavo Turecki; Gustavo H Vazquez; Sidney H Kennedy; Pierre Blier
Journal:  BMC Psychiatry       Date:  2020-06-02       Impact factor: 3.630

Review 6.  Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.

Authors:  Bashkim Kadriu; Laura Musazzi; Ioline D Henter; Morgan Graves; Maurizio Popoli; Carlos A Zarate
Journal:  Int J Neuropsychopharmacol       Date:  2019-02-01       Impact factor: 5.176
  6 in total
  1 in total

1.  Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress.

Authors:  Ashley Bernardo; Philip Lee; Michael Marcotte; Md Yeunus Mian; Sepideh Rezvanian; Dishary Sharmin; Aleksandra Kovačević; Miroslav M Savić; James M Cook; Etienne Sibille; Thomas D Prevot
Journal:  Neuropsychopharmacology       Date:  2022-06-14       Impact factor: 8.294
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.